comparemela.com

Latest Breaking News On - Pharmaceuticals company profile - Page 8 : comparemela.com

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 6 5%

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 6 5%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Up 6 5%

ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Up 6 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) CEO Stephen Davis Sells 11,427 Shares

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the transaction, the chief executive officer now owns 155,231 shares of the company’s […]

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) CEO Stephen Davis Sells 11,427 Shares of Stock

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the sale, the chief executive officer now directly owns 155,231 shares of the […]

X4 Pharmaceuticals (NASDAQ:XFOR) Price Target Increased to $5 00 by Analysts at HC Wainwright

X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) had its target price lifted by equities researchers at HC Wainwright from $3.00 to $5.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 352.49% from the company’s […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.